Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05344469Recruiting
Testing new MS medicines in people with active relapsing MS
This study tests different approved “disease-modifying” MS medicines (shots and pills) in adults with relapsing multiple sclerosis that is currently active. It mainly looks at outcomes based on how newly starting—or recently started—treatments are handled for people with recent relapses and mild disability.
Albstadt, Baden-WurttembergAges 18–100 - NCT05319353RecruitingPhase 3
Maribavir for kids with CMV after transplant
This Phase 3 trial tests maribavir (an anti-CMV medicine) in children and teens who get CMV infection after a stem cell or solid organ transplant. It aims to see whether the drug is safe and well-tolerated, and whether it can reduce the virus in the body.
Wilmington, DelawareAges Up to 17 years - NCT05329103RecruitingPhase 1
Test drug PEEL-224 in advanced solid tumor cancers
This Phase 1 study tests PEEL-224 in people whose solid tumors are advanced and have not responded to standard treatments (or have no approved standard option). It focuses on safety and early signs of whether the drug can help shrink tumors.
Scottsdale, ArizonaAges 18 years+ - NCT05318534RecruitingPhase 1
Testing a new medicine for Cold Agglutinin Disease
This Phase 1 study checks whether an investigational medicine is safe and tolerable, and how the body processes it. For people with Cold Agglutinin Disease, it also looks at early blood markers of whether the disease responds.
LeedsAges 18 years+ - NCT05319730RecruitingPhase 1/Phase 2
Testing new drugs, with or without pembrolizumab, for advanced esophageal cancer
This trial studies investigational cancer medicines, either alone or along with pembrolizumab, for people with advanced esophageal squamous cell cancer whose cancer has grown despite prior immune and platinum-based treatment. It may offer a new option after standard therapy has not worked.
Tucson, ArizonaAges 18 years+ - NCT05318222Recruiting
Virtual genetic evaluation for undiagnosed rare disease
This study helps children who have a rare genetic illness but have not yet received a diagnosis. It uses virtual evaluation to try to find answers and possible next steps for care.
Edinburg, TexasAges 1 day–18 years - NCT05321134Recruiting
Testing single-port robot surgery for colorectal conditions
This study checks how well a newer single-opening (single-port) robot works for colorectal surgery. It may help surgeons perform operations with the robotic system in carefully selected colorectal conditions.
Sacramento, CaliforniaAges 18 years+ - NCT05334069Recruiting
Blood test study for early cancer detection in patients
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
Anchorage, AlaskaAges 40–75 - NCT05328401Recruiting
Laser acupuncture for shoulder pain after stroke
This trial tests whether laser acupuncture can reduce shoulder pain in people recovering from a stroke. It compares outcomes while making sure participants are not using certain pain medicines or shoulder injections that could affect results.
Keelung, TaiwanAges 20 years+ - NCT05313945Recruiting
Compare comfort after passive vs active catheter removal
This study tests which method of removing an in-place urinary (bladder) catheter is more satisfying and comfortable for patients after certain urologic procedures. If you qualify, you may be randomly assigned to one of two removal approaches and asked about your experience.
GrenobleAges 18 years+ - NCT05349513Recruiting
Testing a home-care program for schizophrenia-like disorders
This study tests a specific kind of care delivered in a home-like setting for people with schizophrenia or schizoaffective disorder. It may help the care team understand what kinds of supports work best and improve day-to-day treatment.
PoitiersAges 18–65 - NCT05313191Recruiting
Proton therapy for tumors after prior radiation
This study looks at whether a type of proton beam treatment can be given safely and effectively to tumors that have already been treated with radiation before. It may help people whose tumors came back or persisted after earlier radiation, using a specific proton method called pencil beam scanning.
New York, New YorkAges 18 years+ - NCT05336760Recruiting
ALS study of swallowing comfort, quality of life, and PEG views
This study looks at swallowing problems in people with ALS and how they affect quality of life, including people’s attitudes toward PEG (a feeding tube). It may help researchers understand what support and information could improve comfort and day-to-day living.
LjubljanaAges 18 years+ - NCT05300698Recruiting
Eye imaging test: MRI compared with ultrasound
This study compares two ways to look at the layers of your eye: MRI and a special, non-contact ultrasound. It may help find which test gives clearer information for diagnosing or evaluating eye conditions.
Paris, ParisAges 18 years+ - NCT05305313RecruitingPhase 4
Testing a new propofol dosing method for higher BMI surgeries
This trial studies whether adjusting how propofol (an anesthesia medicine) is dosed based on total body weight improves anesthesia delivery during longer surgeries. It mainly targets people with a higher body mass index having surgery that lasts over an hour.
New Delhi, National Capital Territory of DelhiAges 18–65 - NCT05308888RecruitingPhase 2
PET scan study of heart inflammation after aortic valve replacement
This Phase 2 trial uses a PET scan to study how local inflammation inside the heart affects the heart’s electrical wiring after a minimally invasive aortic valve procedure. The results may help doctors better predict or prevent rhythm and conduction problems after treatment.
BrestAges 18 years+ - NCT05296109Recruiting
3D MRI study of facial nerves in parotid tumors
This trial tests a special 3D MRI picture method to evaluate the facial nerves in people with parotid (salivary gland) tumors. It may help your care team see facial nerve involvement more clearly, which can guide treatment planning.
Hong KongAges 18 years+ - NCT05257746Recruiting
Testing bladder and rectal function after rectal surgery
This study follows people after rectal surgery to check how well the rectum and urinary (bladder) functions work over time. It may help doctors better understand recovery and what can improve quality of life after surgery.
Dresden, SaxonyAges 18 years+ - NCT05303285RecruitingPhase 4
Secukinumab for active ankylosing spondylitis in Chinese adults
This trial studies whether secukinumab (a targeted medicine given by injection) can reduce symptoms and disease activity in adults with active ankylosing spondylitis. You may be considered if other common anti-inflammatory medicines have not worked well enough or you could not take them.
Wuhan, HubeiAges 18–80 - NCT05267912Recruiting
Using tumor organoids to guide treatment for advanced cancers
This study tests whether growing a patient's tumor cells in a dish (called an organoid) can help doctors choose the best next treatment. It is for people with advanced colorectal or pancreatic cancer who have run out of standard options.
Bordeaux, FranceAges 18 years+ - NCT05291507RecruitingEarly Phase 1
MRI-guided focused ultrasound for breast cancer during surgery
This early study tests whether a device that uses focused ultrasound (guided by MRI) can be safely used during surgery for women with invasive breast cancer. It mainly looks at feasibility—whether the treatment can be delivered as planned and is safe.
Salt Lake City, UtahAges 18 years+ - NCT05295433RecruitingPhase 1/Phase 2
Long-term follow-up for an mRNA vaccine dose you already received
This is a follow-up study that checks the long-term safety and health benefits of mRNA-3705 for people who took it in an earlier trial (or had to pause dosing due to COVID-19 vaccination). You may be invited if you completed the earlier study schedule or can transition early because you missed several doses.
Los Angeles, CaliforniaAges 1 year+ - NCT05277168RecruitingPhase 1/Phase 2
Study drug for advanced stomach or pancreatic cancer with Claudin 18.2
This trial tests the safety and side effects of SHR-A1904, and whether it can help people with advanced stomach or pancreatic cancer. To join, your tumor must have high “Claudin 18.2” protein, and you must meet several health and timing requirements.
Miami Beach, FloridaAges 18 years+ - NCT05303064RecruitingPhase 3
Study of weight gain medicine for teens with certain mood or psychosis
This Phase 3 study tests a treatment aimed at reducing unhealthy weight gain in teens with schizophrenia or bipolar I disorder, using changes in BMI (a height-and-weight measure). It may help families who are concerned about weight changes that can happen with some psychiatric medicines.
Dothan, AlabamaAges 10–17
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.